D-0724-2026 Class II Ongoing
FDA drug recall D-0724-2026 was initiated by Rising Pharma Holding, Inc. on Jul 13, 2026 and is designated Class II. Reason for recall: Presence of Precipitate: medication was crystallizing and particles floating in the bottle The recall status is ongoing. Affected quantity: 74208 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jul 13, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 74208 units
Product description
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Reason for recall
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Distribution pattern
Nationwide U.S.A.
Code information
Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0724-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026